Everyones skin is different, and even the gentlest products can cause side effects
P.SarangdharM.AvogaroA
10.1016/j.bbadis.2016.03.010 Biochim
Capital Structure Redeemable Convertible Preferred Stock Redeemable convertible preferred stock consisted of the following at December 31, 2023 and 2022 (in thousands, except share information): In 2017, the Company issued 4,753,466 shares of Series A-1 redeemable convertible preferred stock (the Series A-1 Preferred Stock), 2,948,071 shares of Series A-2 redeemable convertible preferred stock (the Series A-2 Preferred Stock), 203,821 shares of Series A-3 redeemable convertible preferred stock (the Series A-3 Preferred Stock), and 27,643 shares of Series A-4 redeemable convertible preferred stock (the Series A-4 Preferred Stock and together with the Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series A-3 Preferred Stock, the Series A Preferred Stock), and in connection with the settlement of the Simple Agreement for Future Equity (SAFE) instruments that were outstanding

It was originally derived from a protein fragment associated with gastric juice and studied for its protective effects on the gastrointestinal system. Since its development in the 1990s, research has expanded into musculoskeletal healing, where it has shown promising effects in animal models involving tendon, ligament, muscle, and bone injuries. One important caveat regarding BPC-157 is that it is not FDA-approved for human use, and most of what we know comes from preclinical research